Therapeutics informing vaccine development for human leishmaniasis
Toheeb Jumah Poster 2024
Towards a better TB vaccine: understanding improved local immune control by mucosal BCG vaccination
Towards a T cell subset that can control Mycobacterium tuberculosis infection
Tracy Hussell 2019
Training Grant call
17 August 2022
Training Grant Recipients
VALIDATE Fellowships are awarded to excellent Early Career Researcher Members to fund 2 years independent research to support them on their path to independence.
Training Grants Round 13 Awarded
19 July 2022
Training Grants Round 6 Awarded
30 July 2019
Transforming the Immunology Landscape
20 April 2023 to 23 April 2023
Join the BSIA at the new 'Transforming the immunology landscape' event which features an exciting line-up of world-class and influential speakers to celebrate and discuss the current and future impact of immunology.
Translating protective immune signatures in the lung to peripheral biomarkers for TB
Dr Paula Niewold, Leiden University Medical Center (LUMC), Netherlands
Translation Workshop 2024
23 July 2024
Translational Health Science and Technology Institute
India
Tribhuvan University
Nepal
Tropical Diseases Research Centre (TDRC)
Zambia
Tuberculosis
Tuberculosisis is a global disease caused by a bacterium, Mycobacterium tuberculosis. In 2020 10 million people developed TB and 1.5 million died, killing more people every year than HIV or malaria.
Tufária Mussá 2019
Tufária Mussá Poster 2023
Tuhina Gupta Poster 2025
Tulane University
United States of America
Two VALIDATE Funding Schemes Open
04 October 2022
Ugochukwu Madubueze Poster 2024
UK Health Security Agency (UKHSA)
United Kingdom
UN High Level TB Meeting 2018
In 2018 the WHO/UN held the 1st ever UN General Assembly (UNGA) High Level Meeting on tuberculosis (TB) and we asked VALIDATE members to write to their local MP to ensure we maximised its impact
